Logo image of DHCNL

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

NASDAQ:DHCNL - Nasdaq - US25525P3055

15.95  +0.05 (+0.31%)

Fundamental Rating

2

Overall DHCNL gets a fundamental rating of 2 out of 10. We evaluated DHCNL against 129 industry peers in the Diversified REITs industry. DHCNL has a bad profitability rating. Also its financial health evaluation is rather negative. DHCNL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHCNL had negative earnings in the past year.
In the past year DHCNL had a positive cash flow from operations.
DHCNL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DHCNL reported negative operating cash flow in multiple years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.29%, DHCNL is doing worse than 93.65% of the companies in the same industry.
The Return On Equity of DHCNL (-18.81%) is worse than 88.89% of its industry peers.
Industry RankSector Rank
ROA -7.29%
ROE -18.81%
ROIC N/A
ROA(3y)-1.01%
ROA(5y)-1.3%
ROE(3y)-2.2%
ROE(5y)-3.08%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

DHCNL has a worse Gross Margin (17.10%) than 96.83% of its industry peers.
In the last couple of years the Gross Margin of DHCNL has declined.
The Profit Margin and Operating Margin are not available for DHCNL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.61%
GM growth 5Y-22.42%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHCNL has more shares outstanding
The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
The debt/assets ratio for DHCNL is higher compared to a year ago.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

DHCNL has an Altman-Z score of 0.31. This is a bad value and indicates that DHCNL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.31, DHCNL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNL has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.44, DHCNL is doing worse than 61.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.31
ROIC/WACCN/A
WACC7.42%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

DHCNL has a Current Ratio of 5.85. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL has a better Current ratio (5.85) than 94.44% of its industry peers.
A Quick Ratio of 5.85 indicates that DHCNL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.85, DHCNL belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.85
Quick Ratio 5.85
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

DHCNL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.23%.
DHCNL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.62%.
The Revenue has been growing slightly by 4.77% on average over the past years.
EPS 1Y (TTM)-47.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)6.62%
Revenue growth 3Y-4.75%
Revenue growth 5Y4.77%
Sales Q2Q%4.8%

3.2 Future

Based on estimates for the next years, DHCNL will show a small growth in Earnings Per Share. The EPS will grow by 5.26% on average per year.
DHCNL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.77% yearly.
EPS Next Y-61.26%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue Next Year5.41%
Revenue Next 2Y4.93%
Revenue Next 3Y5.77%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHCNL indicates a rather expensive valuation: DHCNL more expensive than 95.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.88
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.46%
EPS Next 3Y5.26%

More info and screens

1

5. Dividend

5.1 Amount

DHCNL has a Yearly Dividend Yield of 1.92%.
Compared to an average industry Dividend Yield of 18.51, DHCNL's dividend is way lower than its industry peers. On top of this 84.92% of the companies listed in the same industry pay a better dividend than DHCNL!
DHCNL's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of DHCNL decreases each year by -51.94%.
DHCNL has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-51.94%
Div Incr Years0
Div Non Decr Years2
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

DHCNL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.5%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (1/21/2025, 8:00:02 PM)

15.95

+0.05 (+0.31%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners74.05%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap3.85B
Analysts48
Price Target25.41 (59.31%)
Short Float %0.01%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0.04
Dividend Growth(5Y)-51.94%
DP-2.5%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.93%
Min EPS beat(2)-23.76%
Max EPS beat(2)107.62%
EPS beat(4)1
Avg EPS beat(4)-3.44%
Min EPS beat(4)-70.3%
Max EPS beat(4)107.62%
EPS beat(8)3
Avg EPS beat(8)9.18%
EPS beat(12)3
Avg EPS beat(12)-12.53%
EPS beat(16)5
Avg EPS beat(16)-7.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)-1.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)-0.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)3
Avg Revenue beat(12)-1.06%
Revenue beat(16)3
Avg Revenue beat(16)-1.67%
PT rev (1m)20.1%
PT rev (3m)30.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.6
P/FCF N/A
P/OCF 44.33
P/B 1.88
P/tB 1.88
EV/EBITDA 29.88
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.93
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)0.36
OCFY2.26%
SpS6.12
BVpS8.49
TBVpS8.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.29%
ROE -18.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.1%
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-1.3%
ROE(3y)-2.2%
ROE(5y)-3.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.61%
GM growth 5Y-22.42%
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 13.46
Cap/Depr 69.24%
Cap/Sales 13.64%
Interest Coverage N/A
Cash Conversion 39.68%
Profit Quality N/A
Current Ratio 5.85
Quick Ratio 5.85
Altman-Z 0.31
F-Score6
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)107.73%
Cap/Depr(5y)97.46%
Cap/Sales(3y)20.76%
Cap/Sales(5y)20.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-61.26%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue 1Y (TTM)6.62%
Revenue growth 3Y-4.75%
Revenue growth 5Y4.77%
Sales Q2Q%4.8%
Revenue Next Year5.41%
Revenue Next 2Y4.93%
Revenue Next 3Y5.77%
Revenue Next 5YN/A
EBIT growth 1Y-20.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year378.31%
EBIT Next 3Y75.54%
EBIT Next 5YN/A
FCF growth 1Y74.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y199.71%
OCF growth 3Y-59.56%
OCF growth 5Y-51.55%